# Broadway Financial Corp \\de\\: financial statements, quarterly

BYFC · Nasdaq · CIK 1001171 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/byfc.md) · [Financials](/companies/byfc/financials.md) · [Filings](/companies/byfc/filings.md) · [Insiders](/companies/byfc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/byfc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.0](/filings/0001140361-24-046491.md) | [0.0 d](/filings/0001140361-25-046590.md) | [0.0](/filings/0001140361-25-047014.md) | [0.0](/filings/0001140361-25-047025.md) | [0.0](/filings/0001140361-26-005265.md) | [0.0 d](/filings/0001140361-26-012311.md) | [0.0](/filings/0001140361-26-021646.md) | [0.0](/filings/0001140361-26-032726.md) | [0.0](/filings/0001140361-26-005265.md) | [0.1 d](/filings/0001140361-26-012311.md) | [0.0](/filings/0001140361-26-021646.md) | [0.0](/filings/0001140361-26-032726.md) |
| Interest expense | $m | [5.2](/filings/0001140361-24-026825.md) | [5.5 d](/filings/0001140361-24-026827.md) | [7.3](/filings/0001140361-24-027470.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.0](/filings/0001140361-25-046590.md) | [1.2](/filings/0001140361-25-046590.md) | [(0.1)](/filings/0001140361-25-047014.md) | [0.1](/filings/0001140361-25-047025.md) | [0.2](/filings/0001140361-26-005265.md) | [0.5](/filings/0001140361-25-046590.md) | [(1.1)](/filings/0001140361-26-021646.md) | [0.3](/filings/0001140361-26-032726.md) | [0.7](/filings/0001140361-26-005265.md) | [0.4 d](/filings/0001140361-26-012311.md) | [0.3](/filings/0001140361-26-021646.md) | [0.3](/filings/0001140361-26-032726.md) |
| Net income | $m | [0.1](/filings/0001140361-25-046590.md) | [2.6](/filings/0001140361-25-046590.md) | [(0.2)](/filings/0001140361-25-047014.md) | [0.3](/filings/0001140361-25-047025.md) | [0.5](/filings/0001140361-26-005265.md) | [1.3](/filings/0001140361-25-046590.md) | [(2.7)](/filings/0001140361-26-021646.md) | [0.8](/filings/0001140361-26-032726.md) | [(23.9)](/filings/0001140361-26-005265.md) | [1.0 d](/filings/0001140361-26-012311.md) | [1.2](/filings/0001140361-26-021646.md) | [1.0](/filings/0001140361-26-032726.md) |
| Diluted EPS | $ per share | [0.01](/filings/0001140361-25-046590.md) | [0.29](/filings/0001140361-25-046590.md) | [(0.02)](/filings/0001140361-25-047014.md) | [0.02](/filings/0001140361-25-047025.md) | [(0.03)](/filings/0001140361-26-005265.md) | [0.06](/filings/0001140361-25-046590.md) | [(0.39)](/filings/0001140361-26-021646.md) | [0.00](/filings/0001140361-26-032726.md) | [(2.86)](/filings/0001140361-26-005265.md) | not reported | [0.05](/filings/0001140361-26-021646.md) | [0.02](/filings/0001140361-26-032726.md) |
| Basic EPS | $ per share | [0.01](/filings/0001140361-25-046590.md) | [0.29](/filings/0001140361-25-046590.md) | [(0.02)](/filings/0001140361-25-047014.md) | [0.02](/filings/0001140361-25-047025.md) | [(0.03)](/filings/0001140361-26-005265.md) | [0.06](/filings/0001140361-25-046590.md) | [(0.39)](/filings/0001140361-26-021646.md) | [0.00](/filings/0001140361-26-032726.md) | [(2.86)](/filings/0001140361-26-005265.md) | not reported | [0.05](/filings/0001140361-26-021646.md) | [0.02](/filings/0001140361-26-032726.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [11.5](/filings/0001140361-25-046590.md) | [105](/filings/0001140361-25-046590.md) | [67.1](/filings/0001140361-25-046590.md) | [89.8](/filings/0001140361-25-046590.md) | [97.1](/filings/0001140361-25-046590.md) | [61.4](/filings/0001140361-26-012311.md) | [15.8](/filings/0001140361-25-047014.md) | [29.5](/filings/0001140361-25-047025.md) | [19.7](/filings/0001140361-26-005265.md) | [10.5](/filings/0001140361-26-032726.md) | [26.6](/filings/0001140361-26-021646.md) | [48.9](/filings/0001140361-26-032726.md) |
| Total assets | $m | [1,269](/filings/0001140361-25-046590.md) | [1,407](/filings/0001140361-25-046590.md) | [1,401](/filings/0001140361-25-046590.md) | [1,399](/filings/0001140361-25-046590.md) | [1,405](/filings/0001140361-25-046590.md) | [1,335](/filings/0001140361-26-012311.md) | [1,259](/filings/0001140361-25-047014.md) | [1,248](/filings/0001140361-25-047025.md) | [1,336](/filings/0001140361-26-005265.md) | [1,346](/filings/0001140361-26-032726.md) | [1,426](/filings/0001140361-26-021646.md) | [1,564](/filings/0001140361-26-032726.md) |
| Total liabilities | $m | [994](/filings/0001140361-25-046590.md) | [1,125](/filings/0001140361-25-046590.md) | [1,120](/filings/0001140361-25-046590.md) | [1,116](/filings/0001140361-25-046590.md) | [1,118](/filings/0001140361-25-046590.md) | [1,050](/filings/0001140361-26-012311.md) | [975](/filings/0001140361-25-047014.md) | [963](/filings/0001140361-25-047025.md) | [1,074](/filings/0001140361-26-005265.md) | [1,083](/filings/0001140361-26-032726.md) | [1,163](/filings/0001140361-26-021646.md) | [1,301](/filings/0001140361-26-032726.md) |
| Shareholders' equity | $m | [275](/filings/0001140361-25-046590.md) | [282](/filings/0001140361-25-046590.md) | [281](/filings/0001140361-25-046590.md) | [282](/filings/0001140361-25-046590.md) | [286](/filings/0001140361-25-046590.md) | [285](/filings/0001140361-26-012311.md) | [284](/filings/0001140361-25-047014.md) | [285](/filings/0001140361-25-047025.md) | [262](/filings/0001140361-26-005265.md) | [263](/filings/0001140361-26-032726.md) | [262](/filings/0001140361-26-021646.md) | [262](/filings/0001140361-26-032726.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1.9 d](/filings/0001140361-24-046491.md) | [3.6 d](/filings/0001140361-25-046590.md) | [(11.7)](/filings/0001140361-25-047014.md) | [9.8 d](/filings/0001140361-25-047025.md) | [6.1 d](/filings/0001140361-26-005265.md) | [(2.8) d](/filings/0001140361-26-012311.md) | [(4.3)](/filings/0001140361-26-021646.md) | [3.0 d](/filings/0001140361-26-032726.md) | [3.8 d](/filings/0001140361-26-005265.md) | [(2.3) d](/filings/0001140361-26-012311.md) | [1.1](/filings/0001140361-26-021646.md) | [4.0 d](/filings/0001140361-26-032726.md) |
| Capital expenditure | $m | [0.1 d](/filings/0001140361-24-046491.md) | [0.1 d](/filings/0001140361-25-046590.md) | [0.1](/filings/0001140361-25-047014.md) | [0.0 d](/filings/0001140361-25-047025.md) | [0.0 d](/filings/0001140361-26-005265.md) | [0.0 d](/filings/0001140361-26-012311.md) | [0.0](/filings/0001140361-26-021646.md) | [0.0 d](/filings/0001140361-26-032726.md) | [0.1 d](/filings/0001140361-26-005265.md) | [0.1 d](/filings/0001140361-26-012311.md) | [0.0](/filings/0001140361-26-021646.md) | [0.3 d](/filings/0001140361-26-032726.md) |
| Dividends paid | $m | [0.0 d](/filings/0001140361-24-046491.md) | not reported | [0.0](/filings/0001140361-25-047014.md) | [0.1 d](/filings/0001140361-24-037316.md) | [0.8 d](/filings/0001140361-24-046491.md) | not reported | [0.8](/filings/0001140361-25-047014.md) | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [8,812](/filings/0001140361-25-046590.md) | [8,826](/filings/0001140361-25-046590.md) | [8,742](/filings/0001140361-25-046590.md) | [8,230](/filings/0001140361-25-047014.md) | [8,597](/filings/0001140361-25-047025.md) | [8,521](/filings/0001140361-26-005265.md) | [8,639](/filings/0001140361-25-046590.md) | [8,547](/filings/0001140361-26-021646.md) | [8,808](/filings/0001140361-26-032726.md) | [8,618](/filings/0001140361-26-005265.md) | [8,816](/filings/0001140361-26-021646.md) | [8,875](/filings/0001140361-26-032726.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 6,145,451 at 2013-11-05, from the cover of the [10-Q filed 2013-11-14](/filings/0001104659-13-084872.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.